Factors associated with Type I and Type II endometrial cancer.
about
Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancerEndometrial Carcinoma: Role of Current and Emerging Biomarkers in Resolving Persistent Clinical DilemmasEtiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial.HNF1B and endometrial cancer risk: results from the PAGE study.Fertility drugs and the risk of breast and gynecologic cancers.Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables.Cigarette smoking and endometrial carcinoma risk: the role of effect modification and tumor heterogeneity.Artemisinin triggers a G1 cell cycle arrest of human Ishikawa endometrial cancer cells and inhibits cyclin-dependent kinase-4 promoter activity and expression by disrupting nuclear factor-κB transcriptional signaling.Trop-2 protein overexpression is an independent marker for predicting disease recurrence in endometrioid endometrial carcinoma.Nationwide surveillance in uterine cancer: survival analysis and the importance of birth cohort: 30-year population-based registry in Taiwan.Identification of optimal reference genes for gene expression normalization in a wide cohort of endometrioid endometrial carcinoma tissuesMetabolic syndrome and risk of endometrial cancer in the united states: a study in the SEER-medicare linked databasePolymerase ɛ (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing.Obesity, diet, physical activity, and health-related quality of life in endometrial cancer survivorsSurvival outcomes in endometrial cancer patients are associated with CXCL12 and estrogen receptor expression.Project for the National Program of Early Diagnosis of Endometrial Cancer Part I.Associations between hepatocyte growth factor, c-Met, and basic fibroblast growth factor and survival in endometrial cancer patients.Impact of histology and surgical approach on survival among women with early-stage, high-grade uterine cancer: An NRG Oncology/Gynecologic Oncology Group ancillary analysis.Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium.Incidence and factors associated with synchronous ovarian and endometrial cancer: a population-based case-control study.Associations of Dietary Long-Chain ω-3 Polyunsaturated Fatty Acids and Fish Consumption With Endometrial Cancer Risk in the Black Women's Health StudyEndometrial cancer risk factors by 2 main histologic subtypes: the NIH-AARP Diet and Health Study.Type I and II endometrial cancers: have they different risk factors?Rare large cell neuroendocrine tumor of the endometrium: A case report and review of the literature.Body Mass Index Is Positively Associated with Endometrial Cancer in Chinese Women, Especially Prior to MenopauseSerum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women.Anthropometric measures and the risk of endometrial cancer, overall and by tumor microsatellite status and histological subtype.Childhood body mass index and height and risk of histologic subtypes of endometrial cancer.Measuring PC activity in endocervical swab may provide a simple and non-invasive method to detect endometrial cancer in post-menopausal women.Targeted therapy in uterine serous carcinoma: an aggressive variant of endometrial cancer.Role of spiral artery Doppler to screen type 2 endometrial cancer cases.Advancements in the use of blood tests for cancer screening in women at high risk for endometrial and breast cancer.Genetics of endometrial cancer.The genetic landscape of endometrial clear cell carcinomas.Loss of Mismatch Repair Protein Expression in Unselected Endometrial Adenocarcinoma Precursor Lesions.Epidemiology of Endometrial Carcinoma: Etiologic Importance of Hormonal and Metabolic Influences.The future therapy of endometrial cancer: microRNA's functionality, capability, and putative clinical application.Obesity, lymphadenectomy and survival outcomes in intermediate to high-risk, early-stage endometrial cancer patients.USA endometrial cancer projections to 2030: should we be concerned?Risk Factors for Endometrial Cancer: Results from a Hospital-Based Case-Control Study
P2860
Q26750563-2B7B7A09-EE56-4252-99A6-A2A463199706Q28074769-2D2D7810-A3B6-4A4E-BC2B-3AA5F39D5242Q30413346-68DDC3C7-6CFE-4420-8864-8F919D11D9D4Q31047674-774E5FCF-8EAE-4CA9-97F6-797809C86586Q33931378-194277FE-DB46-4348-8E15-028E9696B2EDQ34023517-D351029B-3DDF-4C4A-9E16-B6DE4DB06F67Q34118988-96E9CC2F-422A-4A1E-8F48-D097E389F25FQ34231069-318192A5-C85D-494C-B884-A76EB4A6CB4BQ34476583-77255F03-8E86-426E-8969-7BB2831D5C8AQ34516506-8919F4E8-FA4F-4436-89CB-6BFDBEC8FBFBQ34633600-26081236-065E-495D-B8E4-CB7766619C03Q34971006-4D7574C9-D6A9-4E2C-99EF-E51FD2E1AC85Q35007615-BA3E83B6-FFD3-4387-91E4-D6454947AD37Q35770791-B50750FC-A600-41F0-9FB7-9A0829D2A4D6Q35794892-654D8500-87CD-4856-83C4-974B31425573Q36017677-86822DFC-3416-482B-85FA-D02D8488544FQ36072790-625B38E6-F58C-4D20-8DA9-F4347A7168D9Q36164445-90CE7CB6-D762-4EBC-A55E-C21828EA3E9AQ36379977-A513FB9F-5D05-4748-82BE-B477F4AC4125Q36389906-12150DF0-F95C-4F6F-B92C-60481933DBB5Q36493619-FD418480-FE05-4C50-AF45-77A79F04DFE2Q36661765-EF539DC4-AF02-4DD3-BADB-66BF7BA68D28Q36977055-F14C3C34-81F6-4C57-8095-476859A46DD1Q37010942-9A178952-D6C7-410E-80CE-553D6D31F443Q37015755-3A4B2A9B-423F-44CB-B628-DA815C3DDC81Q37059802-BDD9D237-3BAF-490C-BADF-43276BC2747AQ37065996-1632380E-D1F3-4839-8939-69F3DDB67A7EQ37151157-B5CAACA8-46E1-4199-9242-F0A81CAEF058Q37564809-C5B59E01-8FAA-4CDE-8E30-D4F7C2E650C8Q37699264-89DE5968-D0F9-4801-867D-9381B546D112Q37731633-5B5704F3-B1E9-441A-967D-E6426CA64738Q37960202-FD57464D-2512-40A0-82FB-0C726D7B621AQ38212634-53F4D9BF-FCFD-4ABA-B9D1-FD5CBF98161FQ38674086-AE13937E-4C26-4565-ADF3-7A2ABF5120BBQ38710498-C2CA8C51-7C10-4D20-AE0F-CA6D970CFD38Q38788210-054072C4-76D1-4F71-B099-1F7CC8205CACQ38820391-BE1D2167-CB9D-4587-9F2F-6E29E49804CBQ39038420-63411F46-E95A-40CA-AD03-6C4186BB862CQ39069499-D2FC4EC2-6BCD-4B0F-94BE-01C3BE9232D3Q39136665-64460A2A-899D-45ED-98D4-080160E322E7
P2860
Factors associated with Type I and Type II endometrial cancer.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Factors associated with Type I and Type II endometrial cancer.
@ast
Factors associated with Type I and Type II endometrial cancer.
@en
Factors associated with Type I and Type II endometrial cancer.
@nl
type
label
Factors associated with Type I and Type II endometrial cancer.
@ast
Factors associated with Type I and Type II endometrial cancer.
@en
Factors associated with Type I and Type II endometrial cancer.
@nl
prefLabel
Factors associated with Type I and Type II endometrial cancer.
@ast
Factors associated with Type I and Type II endometrial cancer.
@en
Factors associated with Type I and Type II endometrial cancer.
@nl
P2093
P2860
P1476
Factors associated with Type I and Type II endometrial cancer.
@en
P2093
Ashley S Felix
Joel L Weissfeld
Mamatha Chivukula
Robert Bowser
Robert P Edwards
Roslyn A Stone
P2860
P2888
P304
P356
10.1007/S10552-010-9612-8
P50
P577
2010-07-14T00:00:00Z